Clinical evaluation of multiple sclerosis:: quantification by use of scales

被引:6
|
作者
Izquierdo, G [1 ]
Ruiz-Peña, JL [1 ]
机构
[1] Hop Univ Virgen Macarena, Serv Neurol, Unidad Esclerosis, E-41009 Seville, Spain
关键词
clinical evaluation; cognitive impairment; EDSS; fatigue; multiple sclerosis; functional composite; scales;
D O I
10.33588/rn.3602.2002350
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Clinical evaluation is indispensable in multiple sclerosis (MS)for the quantitative measurement of the extent of the disorder, which is in turn required to find out how the disease is evolving and the influence the different forms of treatment are having on it, both in the experimental phase and in the usual monitoring they are subjected to. Method We review the different scales that are used to evaluate the distinct symptomatic and functional aspects of MS and the repercussions these have on the extent of disability displayed in the patient's social and personal life. Although in recent years, the EDSS has been an essential, irreplaceable scale in MS, other instruments of measurement that complement it have also begun to appear. The fatigue, cognitive function and quality of life scales are being used more and more frequently. The Multiple Sclerosis Functional Composite is an instrument that is used more and more frequently in MS and has proved to be highly sensitive in the evaluation of very important clinical trials. Conclusions. The lack of correlation between the distinct scales corroborates the fact that they measure complementary aspects of MS.
引用
收藏
页码:145 / 152
页数:8
相关论文
共 50 条
  • [21] Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses
    Bin Sawad, Aseel
    Seoane-Vazquez, Enrique
    Rodriguez-Monguio, Rosa
    Turkistani, Fatema
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (12) : 1969 - 1974
  • [22] Clinical Neurophysiology of Multiple Sclerosis
    Habek, Mario
    Adamec, Ivan
    Barun, Barbara
    Crnosija, Luka
    Gabelic, Tereza
    Skoric, Magdalena Krbot
    MULTIPLE SCLEROSIS: BENCH TO BEDSIDE: GLOBAL PERSPECTIVES ON A SILENT KILLER, 2017, 958 : 129 - 139
  • [23] Scales for functional assessment in multiple sclerosis
    Prieto-González, JM
    REVISTA DE NEUROLOGIA, 2000, 30 (12) : 1246 - 1252
  • [24] Neuropsychological evaluation in multiple sclerosis
    Arnett, P.
    Forn, C.
    REVISTA DE NEUROLOGIA, 2007, 44 (03) : 166 - 172
  • [25] Clinical consequences of MRI activity in treated multiple sclerosis
    Cadavid, Diego
    Kim, Soyeon
    Peng, Bo
    Skurnick, Joan
    Younes, Maha
    Hill, James
    Wolansky, Leo J.
    Cook, Stuart D.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (09) : 1113 - 1121
  • [26] Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis
    Notcutt, William G.
    NEUROTHERAPEUTICS, 2015, 12 (04) : 769 - 777
  • [27] Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis
    William G. Notcutt
    Neurotherapeutics, 2015, 12 : 769 - 777
  • [28] Validity of six balance disorders scales in persons with multiple sclerosis
    Cattaneo, Davide
    Regola, Alberto
    Meotti, Matteo
    DISABILITY AND REHABILITATION, 2006, 28 (12) : 789 - 795
  • [29] EVALUATION OF ANTIPYRETICS USE AND HEAT SENSITIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS AND IT IS IMPACT ON QOL
    Alhossan, Abdulaziz
    Alaifan, Noura F.
    Althwaini, Badria T.
    Ahmad, Ajaz
    FARMACIA, 2022, 70 (04) : 704 - 711
  • [30] The search for responsive clinical endpoints in primary progressive multiple sclerosis
    Bosma, L. V. A. E.
    Kragt, J. J.
    Brieva, L.
    Khaleeli, Z.
    Montalban, X.
    Polman, C. H.
    Thompson, A. J.
    Tintore, M.
    Uitdehaag, B. M. J.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (06) : 715 - 720